Analysis of the Regulatory Capacity to Assure the Quality of Antimalarial Medicines in Selected Countries of the Greater Mekong Subregion of Asia. March 2015

Lee, D., E. Kim, and B. Santoso. Abstract: SIAPS conducted a review of regulatory and quality assurance efforts in the GMS with the following objectives To inform PMI of past and current initiatives to improve the capacity of the region to combat counterfeit, substandard, and banned antimalarial medicines To understand the current barriers to effective medicine quality control for malaria To recommend specific areas of focus or interventions to further improve regional and country capacity to combat counterfeit, substandard, and banned or illegal antimalarial medicines

[Communicable Disease]

Books/Monographs

Download File